BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10651986)

  • 1. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
    Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
    J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.
    Hosoya Y; Gemma A; Seike M; Kurimoto F; Uematsu K; Hibino S; Yoshimura A; Shibuya M; Kudoh S
    Lung Cancer; 1999 Aug; 25(2):87-93. PubMed ID: 10470842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
    Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
    Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors.
    Kawamura N; Nagai H; Bando K; Koyama M; Matsumoto S; Tajiri T; Onda M; Fujimoto J; Ueki T; Konishi N; Shiba T; Emi M
    Jpn J Cancer Res; 1999 Apr; 90(4):413-8. PubMed ID: 10363579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
    Moritake H; Horii Y; Kuroda H; Sugimoto T
    Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression.
    Poetsch M; Dittberner T; Woenckhaus C
    Cancer Genet Cytogenet; 2001 Feb; 125(1):21-6. PubMed ID: 11297763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas.
    Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G
    Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
    Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
    Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
    J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
    Tsao H; Zhang X; Fowlkes K; Haluska FG
    Cancer Res; 2000 Apr; 60(7):1800-4. PubMed ID: 10766161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
    Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.